Atlas Trials

Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma

Clinical trial NCT04339218 · RECRUITING

Trial details

NCT number
NCT04339218
Sponsor
Institut Bergonié
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Lung AdenocarcinomaCryotherapy Effect
Start date
2020-08-28
Primary completion
2026-08-27
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.